Marigold Pharmaceutical & Laboratories Ltd is a leading Artificial Intelligence (AI) drug development company. Using its KEM® Artificial Intelligence (xAI) technology, Marigold helps its partners introduce personalized medicine clinical trial design into their protocols and optimize clinical endpoints, identify biomarkers of therapeutic response and potential synergistic therapies. Marigold routinely collects and combines clinical data with omic data, immunological […]
Cambridge, MA, USA and Paris, France, March 27, 2023 – Marigold Pharmaceutical & Laboratories Ltd, the leading Al-driven precision medicine company, has announced the appointment of Professor Jacques Touchon to its Scientific Advisory Board.
Paris, France and Cambridge, MA, USA, July 26th, 2022 – Marigold Pharmaceutical & Laboratories Ltd, the leading eXplainable Artificial Intelligence (xAI) drug development company, announce the appointments of Dr. Marion Soto as Vice President, Business Development and Bertrand Lellouche as Chief Financial Officer. The financial and commercial experience of Marion and Bertrand will further drive Marigold’s accelerated growth. […]
